Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after surgery to help them recover fast. Heart pump devices have risen in clinical significance as a potential therapeutic option for several patients to get mechanical circulatory support. The growing morbidity and mortality of heart failure, particularly in developed nations, is a key factor driving the demand for ventricular assist devices. In particular, left ventricular assist devices (LVAD) is increasingly being considered as the standard of cardiac care for patients with advanced heart failure. The rising popularity of minimally invasive surgical procedures in cardiology is leading to the demand for new generation of pumps. Together with this, rapid advances in surgical technique for ventricular assist devices implantation are also underpinning the rapid expansion of the heart pump device market.
Request Sample Copy of the Report @
Considerable progress made in post-operative care in recent years and meticulous planning done for pre-operative technique, coupled with the optimal choice of patients, are factors enhancing the effectiveness and success of LVAD implantation. Rapid improvements in recent years in device designs are supporting the substantial expansion of the market. The growing number of approval for heart pump devices by regulatory agencies, notably the U.S. FDA, is imparting significant momentum to the growth of the market. The growing number of single-center and multi-center studies for testing efficacy of various types of heart pump devices augurs well for the market. Such studies also focus on assessing the impact of LVAD on heart transplant outcomes, taking into account any probable adverse outcomes.
Global Heart Pump Device Market: Overview
A heart pump device is a mechanical pump that's used to support heart function and blood flow in people who have weakened hearts.
The device takes blood from a lower chamber of the heart and helps pump it to the body and vital organs, just as a healthy heart would. A heart pump may be used if one or both of the heart's lower chambers, called the ventricles don't work properly. The basic parts of a heart pump include: a small tube that carries blood out of your heart into a pump; another tube that carries blood from the pump to your blood vessels, which deliver the blood to your body; and a power source. The power source is connected to a control unit that monitors the pump’s functions. The control unit gives warnings, or alarms, if the power is low or if it senses that the device isn't working right. Some heart pumps pump blood like the heart does, with a pumping action. Other devices keep up a continuous flow of blood.
Request TOC of the Report @
The report provides a comprehensive analysis of the heart pumps device market’s segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for supplier. This report also examines the technologies, markets and factors influencing the markets for heart pump devices. Market forecasts are based on historical activity and current opportunities, technical advances and challenges.
Global Heart Pump Device Market: Key Trends
The two basic types of VADs are a left ventricular assist device (LVAD) and a right ventricular assist device (RVAD). If both types are used at the same time, they may be called a biventricular assist device (BIVAD).The LVAD is the most common type of VAD. It helps the left ventricle pump blood to the aorta. RVADs usually are used only for short-term support of the right ventricle after LVAD surgery or other heart surgery. An RVAD helps the right ventricle pump blood to the pulmonary (PULL-mun-ary) artery.
Rising prevalence of cardiovascular diseases, increasing number of regulatory approvals, and a huge gap between the demand and supply of donor hearts is driving the demand for heart pump devices. High growth in the ventricular assist devices market can be primarily attributed to the increased dependency on ventricular assist devices for the treatment of heart failure and technological advancements to improve the safety of these devices. The high cost of devices and implantation procedures and poor reimbursement scenario in developing countries is expected to restrain the growth of this market during the forecast period.
Global Heart Pump Device Market: Market Potential
The continuously rapid advancements in the assist devices technologies and the novel applications of the existing treatments have led to an increase in the cardiac assist devices. In March 2015, FDA approved the Impella 2.5 System, which helps the patients in maintaining a stable heart function and circulation during certain high-risk percutaneous coronary intervention (HRPCI) procedures. Engineers are also exploring many other innovative solutions which helps in the implant success and is driving the cardiac assist devices market. Hence, the market is dependent upon the large number of innovations for growth.
Read Comprehensive Overview of Report @
Global Heart Pump Device Market: Regional Outlook
On the basis of geographical segmentation, the global heart pump devices market has been segmented into- Europe, Asia Pacific, North America, Latin America, and the Middle East and Africa. Among these, North America is expected to emerge as the leading region in the market and the large share of this region can primarily be attributed to the rising prevalence of cardiovascular diseases, favorable reimbursement scenario, and the increasing number of regulatory approvals.
Global Heart Pump Device Market: Competitive Analysis
Some of the prominent players operating in the global heart pump devices market are BerlinHeart, Medtronic, St. Jude Medical, Terumo, Jarvik Heart, SynCardia Systems, Getinge, Teleflex, and Abiomed.
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends. Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.
3739 Balboa St # 1097,
San Francisco, CA 94121
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart here
News-ID: 1422210 • Views: 119
More Releases from TMR Research
Hydrolyzed Plant Proteins Market Booming Global Industry Investments and future …
Global Hydrolyzed Plant Proteins Market: Overview Hydrolyzed plant proteins have found use in a wide range of applications in the food and beverages industry. Most commonly, the protein is used to enhance flavor in several processed food products. Several functional characteristics are key to the growing popularity of these proteins. Proteins from oil-producing plants have excellent fat binding and emulsification properties, which are being utilized by hydrolyzing these for applications that
Rose Extracts Market 2028 | Young Living Essential Oils, Thracian Oils Ltd., Fle …
Global Rose Extracts Market: Overview Pharmacological properties of key species of rose flowers are well known, and several companies have been utilizing these for skin care. This is one of the key trends propelling the steady evolution of the rose extracts market. A growing body of in-vivo and in-vitro clinical studies over the past few years have underscored the therapeutic potential of rose extracts. In skin care, rose extracts have been
Global Fruit Tea Market Analysis, Size, Share, Growth & Forecast 2018-2028: Tata …
Global Fruit Tea Market: Overview Based on the nutritive value like vitamin C, and health benefits such as great antioxidant are some of the reasons that are boosting the demand for fruit tea across the globe. Moreover, the growing popularity of the beverage in health cautious genre of population is also a crucial factor that is propelling the demand for fruit tea market. Based on these factors the global fruit
Dairy Desserts Market 2028 | General Mills Inc., Royal FrieslandCampina NV, Nest …
Global Dairy Desserts Market: Overview Who doesn’t love a good dessert after a delicious dinner or lunch? Though they are filled with high calories, they are highly in demand. However, dairy desserts are something that everybody cherishes. The variety in taste and shapes, they are being loved by every age group. Based on the delicious taste and widespread acceptance the global dairy desserts market is expected to grow substantially in the
More Releases for Heart
Heart Congress 2019
Coalesce Research Group proudly announces the “International Conference on Heart & Clinical Cardiology Research” at Osaka, Japan during November 14-15, 2019. This Conference will be perfect platform for scientists, professors, healthcare professionals and cardiologists. Heart Congress 2019 is designed to provide diverse and recent research education on cardiovascular disease that keeps medical professionals along with issues heartrending on diagnosis, treatment of Cardiac disorders and prevention. In recent years, cardiac and
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an
Prosthetic Heart Valve Market
Prosthetic (artificial) heart valve refers to a device implanted in the heart of a patient suffering from valvular heart disease. A cardiac surgery is performed to replace the abnormal heart valve with a prosthetic heart valve. Replacement of a diseased valve with a prosthetic heart valve results in reduction in morbidity and mortality associated with the cardiac valve disorder. When the treatment of heart valve disease reaches a stage where
Global Heart Implants Market
The Heart Implants Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. In a growing cardiac implants market where profits and growth prospects run together, many companies are vying to plunge into this untapped market. Heart implants are end-stage operations, where a failing
Heal Your Heart
The Enhanced External Counter Pulsation (EECP) treatment, which helps treat cardiac patients non-surgically without risk, for the first time in the state. "If you have heart disease, you probably know all about statins (cholesterol lowering medications) and beta blockers (Blood Pressure Medication), angioplasty and bypass surgery, and the benefits of regular exercise," explains Dr Ajith Joy. K, the chief executive officer. "What is to be done when all these treatments fail or